Melanoma research
A specialist journal devoted to melanoma, from tumour genetics and immunology to case reports and clinical studies of targeted and immune therapies.
Overview
Melanoma Research is published by Lippincott Williams & Wilkins, part of Wolters Kluwer, and is hosted on the Ovid journals platform. The journal page lists six issues a year under Editors-in-Chief F. J. Lejeune and W. J. Storkus and shows a mix of clinical and laboratory papers on melanoma: recent issue highlights include a case report of haemophagocytic lymphohistiocytosis and posterior reversible encephalopathy syndrome during BRAF/MEK inhibitor therapy after immune checkpoint blockade, and a study associating chemokine and chemokine receptor gene variants with multiple primary melanoma. NLM records the journal as starting in 1991 (print ISSN 0960-8931, electronic ISSN 1473-5636), published in London, and currently indexed in MEDLINE.
Pages like this
not linked directly; found by shared links- JournalPigment cell & melanoma research
Shares Uveal melanoma, PubMed & Europe PMC, Melanoma.
- CollectionMelanoma Research Alliance (MRA)
Shares Uveal melanoma, Melanoma.
- PersonPaul Nathan
Shares Uveal melanoma, Melanoma.
- PersonSapna P. Patel
Shares Uveal melanoma, Melanoma.
- PersonRichard D. Carvajal
Shares Uveal melanoma, Melanoma.
- CompanyImmunocore
Shares Uveal melanoma, Melanoma.
- Targetgp100 (PMEL)
Shares Uveal melanoma, Melanoma.
- TermHLA-A*02:01 restriction
Shares Uveal melanoma, Melanoma.